FSHR inactivating mutations may cause primary or secondary amenorrhea, infertility, and premature ovarian failure [10]; whereas activating mutations can predispose to ovarian hyperstimulation syndrome, as a consequence of exogenous FSH administration, or to a spontaneous onset [10–12]. The gene discussed is FSHR; the disease is Infertility.